Medical Tips Online

  •  

PhRMA report: 234 medicines in development for special health care needs of children

June 08, 2019

The medicines listed in the report include treatments being developed by biopharmaceutical research companies in Illinois -- Abbott Laboratories in Abbott Park, Hospira in Lake Forest, Neopharm in Waukegan and Takeda Pharmaceuticals, Astellas Pharma and Lundbeck, all located in Deerfield.  In addition to creating new medicines, biopharmaceutical companies are also testing many existing treatments to determine safe and effective dosage levels for children.  The Tufts University Center for the Study of Drug Development says more than 120 approved medications now contain new safety, efficacy, dosing and risk information for children and teenagers in their labeling.  

Bettis, a 12-year NFL veteran when he retired in 2005, appeared at the news conference to discuss his advocacy for patients who suffer from asthma, the leading chronic disease among American children.  Diagnosed with asthma at 14, Bettis went on to play football at the University of Notre Dame and had a stellar NFL career, playing with the St. Louis Rams and Pittsburgh Steelers.  In 2005, he helped lead the Steelers to a Super Bowl victory in his home town of Detroit.  "I'm living proof that patients don't have to let asthma stop them," he said.  "That's why educating Americans about asthma control is so important to me."

Bruschi, the other former NFL great at today's press conference, stressed his passion for helping sick children understand there is hope.  The father of three young sons, he is recognized for his work with pediatric patients.  Among his many citations and awards is the 2007 Wish Hero Award from the Massachusetts Make-A-Wish Foundation.  The award is given to individuals and organizations "that bring hope, strength and joy" to sick children all over Massachusetts.

"There is nothing more important than the health and happiness of our children," Bruschi said.  "It's an honor when someone asks me to talk to sick kids who are facing life-threatening situations.  It's something I'm proud to do.  Our children are the future of America."        

Both Bruschi and Bettis also emphasized the importance of patient assistance programs for pediatric patients whose families are uninsured and struggling financially to make sure they receive the care they need.  They said it was important for patients to learn about the Partnership for Prescription Assistance (PPA).

SOURCE Pharmaceutical Research and Manufacturers of America